Myocarditis with tremelimumab plus durvalumab combination therapy for endometrial cancer: A case report

BACKGROUND: Fulminant myocarditis has been reported in patients treated with immune checkpoint inhibitors. We present the first described case of acute immune-mediated myocarditis and myositis associated with durvalumab plus tremelimumab combination therapy. The patient was undergoing treatment for...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmood, Syed S., Chen, Carol L., Shapnik, Natalie, Krishnan, Udhay, Singh, Harsimran S., Makker, Vicky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005798/
https://www.ncbi.nlm.nih.gov/pubmed/29922709
http://dx.doi.org/10.1016/j.gore.2018.05.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005798/
https://www.ncbi.nlm.nih.gov/pubmed/29922709
http://dx.doi.org/10.1016/j.gore.2018.05.014

Ejemplares similares